Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO-TAT-2020-1000x250

TAT congresses are annual meetings on new molecular targets and innovative cancer therapeutics in the early phases of clinical development.

Add to these features the high scientific standards, informal atmosphere, and active participation by the world’s leading phase 1 investigators, and you will understand why the TAT Congress has become the prime international anticancer drug development meeting.

Fast Facts: Targeted Anticancer Therapies Congress 2020

  • Expecting over 400 participants
  • No parallel sessions
  • Possibility to host a satellite symposium
  • More than 60 internationally renowned faculty
  • Excellent networking opportunities

Past attendance

ESMO gratefully acknowledges the valuable contribution of the following organisations in the TAT Congresses over the years.

Past attendees

4clinics

Celgene France

MSD

AbbVie

Daiichi Sankyo Cancer Enterprise

Novartis

Active Motif

ESMO

Orion Pharma

Adaptive Biotechnologies

GSK

Pfizer

Amgen

Illumina

PharmaMar

Amoy Diagnostics Co, Ltd.

Innate Pharma

Pierre Fabre

Astex Pharmaceuticals, Inc.

INC

Roche

AstraZeneca France

Incyte Corporation

Sanofi

AstraZeneca MedImmune

Immodulon Therapeutics

Servier Oncology

Bavarian Nordic

Ipsen Pharma

Syneos Health

Bayer

Janssen Pharmaceutical Research & Development, L.C.C.

SIRIC-SOCRATE

BlueDNAcompanion

Lilly

Takeda

Boehringer Ingelheim

Merck

Tesaro

Bristol-Myers Squibb

MedImmune

How can I participate in ESMO Targeted Anticancer Therapies Congress 2020?

At ESMO we are committed to providing our industry partners with a variety of solutions to facilitate their presence at our congress.

Contact the ESMO Strategic Partnerships Team for more details. We look forward to hearing from you!

Who has already signed up?

ESMO gratefully acknowledges the valuable contribution the following organisations have made to the Targeted Anticancer Therapies Congress 2020. (As of February 2020):

TAT 2020 Industry Participation

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings